The company, whose FDA-approved products include the myeloma drug Darzalex and the chronic leukemia drug Arzerra, hopes to launch its own proprietary product by 2025.
But he’s sure it’ll all work out in the end, or something.
Atul Gawande’s got this, in his spare time.
Supreme Court Finds Law Unfair To Fathers, Decides To Treat Mothers Just As Bad Above The Law Trump's Tweets Must Now Be Taken Seriously: The 9th Circuit's Travel Ban Ruling Declares The President's Twitter Feed Is A Legally Binding Stream Of Consciousness How Appealing What All This Cancer News Means For Medicine At Large MedCity News Iranian Agreement With Russia Bypasses US Dollar Through Bartering Breaking Energy
Clinton Foundation’s Real Sin Was Helping Black And Brown Foreigners Instead Of Puppies Above The Law Reject Ugly Political Attacks In Kansas And Retain Supreme Court Justices How Appealing ACOs Saved Medicare $466M In 2015, But Nearly Half Produced No Savings MedCity News Greater Flexibility In Challenging Pipeline Takings Breaking Energy
The Dan Markel Case: Prosecutors Want To Know Who Paid For These Breast Implants Above The Law Inside The Conservative Push For States To Amend The Constitution How Appealing Diabetes Is Actually Three Different Diseases Requiring Different Engagement, Monitoring And Management MedCity News US CO2 Emissions From Natural Gas Will Top Coal In 2016 Breaking Energy
The Billable Hour Is A Feminist Issue Above The Law Justices Haven't Ended Abortion Restrictions Yet How Appealing The Potential Impact Of Brexit On The EU Emission Trading System And Future UK Climate Policy Breaking Energy Study Shows Electronic Monitoring Of Hand Hygiene Lowers MRSA Rates MedCity News
Are Long Death Penalty Delays Unconstitutional? How Appealing 52 Years After Being Wrongfully Convicted, Man Finally Gets Exonerated And Has One Thing On His Mind Above The Law Communication, Care Continuity Often Break Down At Hospital Discharge MedCity News As Germany Curtails Wind And Solar, Billion-Euro Grid Projects Help Bring More Green Power On-Line Breaking Energy
Antonin Scalia's Rightful Revolution How Appealing Harvard Law Student Is Rude, Insufferable And Anti-Semitic Above The Law Ben Carson The Paradox: A Respected Surgeon Now In Search Of Presidency, Baffling Science-Minded Americans MedCity News Cities Are ‘Smartening Up’ For The Future With IoT Breaking Energy
'It Was Just Awful': The Clarence Thomas Hearings, In The Words Of Those Who Were There How Appealing Leveraging Shame And The Presumption Of Guilt To Destroy Lives And Punish Consenting Adults Above The Law Study: Telemedicine Sucks As Much As In-Person Care MedCity News Poll: Americans Sound Off On RFS Breaking Energy
The hedge fund manager turned pharma CEO should have "turned" more carefully.
Everyone's least favorite pharma bro has entered the 36th Chamber of sucking.
The much-reviled pharma company is feeling sad, and oh-so-lonely.
Martin Shkreli is still playing dates on his "Unrepentant A$$hole" Tour.
Everyone's favorite price-gouging emo-rapping hedge fund-dropout is now CEO of a publicly-traded company.
Distressed debt traders? Not so much!